These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effect of vitamin E, vitamin C and beta-carotene on LDL oxidation and atherosclerosis. Jialal I; Fuller CJ Can J Cardiol; 1995 Oct; 11 Suppl G():97G-103G. PubMed ID: 7585302 [TBL] [Abstract][Full Text] [Related]
24. Oxidative stress, endothelial function and coronary atherosclerosis. Anderson TJ Cardiologia; 1997 Jul; 42(7):701-14. PubMed ID: 9270179 [No Abstract] [Full Text] [Related]
25. [Current data on the pathogenesis of atherosclerosis (I)]. Niţă M Rev Med Chir Soc Med Nat Iasi; 1993; 97(2):205-11. PubMed ID: 7997658 [No Abstract] [Full Text] [Related]
26. L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease. Yin WH; Chen JW; Tsai C; Chiang MC; Young MS; Lin SJ Clin Nutr; 2005 Dec; 24(6):988-97. PubMed ID: 16140428 [TBL] [Abstract][Full Text] [Related]
27. Role of oxidized LDL and antioxidants in atherosclerosis. Steinberg D Adv Exp Med Biol; 1995; 369():39-48. PubMed ID: 7598015 [No Abstract] [Full Text] [Related]
28. Uptake of oxidized LDL by human atherosclerotic plaque. Iuliano L; Signore A; Violi F Circulation; 1997 Sep; 96(6):2093-4. PubMed ID: 9323116 [No Abstract] [Full Text] [Related]
29. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies. Napoli C G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066 [TBL] [Abstract][Full Text] [Related]
30. Iron and atherosclerosis. Qayyum R; Schulman P Clin Cardiol; 2005 Mar; 28(3):119-22. PubMed ID: 15813617 [TBL] [Abstract][Full Text] [Related]
31. Newly recognized causes of atherosclerosis: the role of microorganisms and of vascular iron overload. Jacob HS J Lab Clin Med; 1994 Jun; 123(6):808-16. PubMed ID: 8201257 [TBL] [Abstract][Full Text] [Related]
32. [Atherosclerosis partly due to local vasculitis]. van Deventer SJ; Kastelein JJ; ten Cate JW Ned Tijdschr Geneeskd; 1994 Feb; 138(9):443-8. PubMed ID: 8133943 [No Abstract] [Full Text] [Related]
33. [Lipoproteins, antioxidants, and coronary cardiopathy]. Guimarães AC Arq Bras Cardiol; 1995 Sep; 65(3):289-95. PubMed ID: 8579520 [No Abstract] [Full Text] [Related]
34. [The role of immune inflammation in atherogenesis]. Nagornev VA; Rabinovich VS Vopr Med Khim; 1997; 43(5):339-48. PubMed ID: 9446324 [TBL] [Abstract][Full Text] [Related]
35. [Antioxidants, oxidation of LDL and atherosclerosis]. Salonen JT; Kovanen PT; Ylä-Herttuala S; Korpela H Duodecim; 1991; 107(15):1232-9. PubMed ID: 1365345 [No Abstract] [Full Text] [Related]
37. Interactions between the renin-angiotensin system and dyslipidemia: relevance in the therapy of hypertension and coronary heart disease. Singh BM; Mehta JL Arch Intern Med; 2003 Jun; 163(11):1296-304. PubMed ID: 12796065 [TBL] [Abstract][Full Text] [Related]
38. [Progress in the study of lipoprotein metabolism and atherosclerosis: role of blood lipoproteins and pathogenesis of atherosclerosis]. Kawamura M; Naito C Nihon Rinsho; 1988 Mar; 46(3):621-8. PubMed ID: 3404688 [No Abstract] [Full Text] [Related]
39. Evidence for the in vivo generation of oxidatively modified epitopes in patients with atherosclerotic endothelium. Le NA; Li X; Kyung S; Brown WV Metabolism; 2000 Oct; 49(10):1271-7. PubMed ID: 11079815 [TBL] [Abstract][Full Text] [Related]
40. [The role of the oxidative modification of LDL in the pathogenesis of atherosclerosis]. Gudev A Mol Med (Sofia); 1996; 1(1):31-8. PubMed ID: 8974763 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]